NIVF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NewGenIVF Group Ltd (NIVF) is not a strong buy for a beginner, long-term investor at this moment. The company's financial performance is significantly declining, technical indicators are bearish, and there are no strong positive catalysts or trading signals to justify an immediate investment. It is better to wait for improved financials or stronger technical signals before considering this stock.
The stock is currently oversold with an RSI of 17.896, but moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The MACD histogram is positive but contracting, indicating weak momentum. The pre-market price is down 0.25%, and the stock is trading below key support levels, with S1 at 0.624 and S2 at 0.548.
The company signed a Memorandum of Understanding with Women in Web3 Hong Kong to enhance women's health awareness, which could improve brand visibility and public perception.
Additionally, there are no significant hedge fund or insider trading trends to indicate confidence in the stock.
In 2025/Q3, the company's revenue dropped by -12.94% YoY, net income plummeted by -84822.54% YoY, EPS declined by -430.88% YoY, and gross margin fell by -79.11% YoY, indicating severe financial underperformance.
No recent analyst rating or price target data is available for this stock.
